229 related articles for article (PubMed ID: 36900856)
1. An Evolving HIV Epidemic in the Middle East and North Africa (MENA) Region: A Scoping Review.
Karbasi A; Fordjuoh J; Abbas M; Iloegbu C; Patena J; Adenikinju D; Vieira D; Gyamfi J; Peprah E
Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36900856
[TBL] [Abstract][Full Text] [Related]
2. HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis.
Mumtaz GR; Weiss HA; Thomas SL; Riome S; Setayesh H; Riedner G; Semini I; Tawil O; Akala FA; Wilson D; Abu-Raddad LJ
PLoS Med; 2014 Jun; 11(6):e1001663. PubMed ID: 24937136
[TBL] [Abstract][Full Text] [Related]
3. HIV incidence among people who inject drugs in the Middle East and North Africa: mathematical modelling analysis.
Mumtaz GR; Awad SF; Feizzadeh A; Weiss HA; Abu-Raddad LJ
J Int AIDS Soc; 2018 Mar; 21(3):e25102. PubMed ID: 29577623
[TBL] [Abstract][Full Text] [Related]
4. Understanding the epidemiological HIV risk factors and underlying risk context for youth residing in or originating from the Middle East and North Africa (MENA) region: A scoping review of the literature.
Kteily-Hawa R; Hawa AC; Gogolishvili D; Al Akel M; Andruszkiewicz N; Vijayanathan H; Loutfy M
PLoS One; 2022; 17(1):e0260935. PubMed ID: 34995320
[TBL] [Abstract][Full Text] [Related]
5. Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North Africa.
Mumtaz GR; Weiss HA; Vickerman P; Larke N; Abu-Raddad LJ
AIDS; 2015 Aug; 29(13):1701-10. PubMed ID: 26372281
[TBL] [Abstract][Full Text] [Related]
6. The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa.
Mahmud S; Mumtaz GR; Chemaitelly H; Al Kanaani Z; Kouyoumjian SP; Hermez JG; Abu-Raddad LJ
Addiction; 2020 Jul; 115(7):1244-1262. PubMed ID: 32009283
[TBL] [Abstract][Full Text] [Related]
7. HIV/AIDS: trends in the Middle East and North Africa region.
Gökengin D; Doroudi F; Tohme J; Collins B; Madani N
Int J Infect Dis; 2016 Mar; 44():66-73. PubMed ID: 26948920
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of HIV infection in the Middle East and North Africa.
Abu-Raddad LJ; Hilmi N; Mumtaz G; Benkirane M; Akala FA; Riedner G; Tawil O; Wilson D
AIDS; 2010 Jul; 24 Suppl 2():S5-23. PubMed ID: 20610949
[TBL] [Abstract][Full Text] [Related]
9. The emerging face of the HIV epidemic in the Middle East and North Africa.
Mumtaz GR; Riedner G; Abu-Raddad LJ
Curr Opin HIV AIDS; 2014 Mar; 9(2):183-91. PubMed ID: 24445372
[TBL] [Abstract][Full Text] [Related]
10. Status of HIV and hepatitis C virus infections among prisoners in the Middle East and North Africa: review and synthesis.
Heijnen M; Mumtaz GR; Abu-Raddad LJ
J Int AIDS Soc; 2016; 19(1):20873. PubMed ID: 27237131
[TBL] [Abstract][Full Text] [Related]
11. Drug policy and harm reduction in the Middle East and North Africa: The role of civil society.
Aaraj E; Jreij Abou Chrouch M
Int J Drug Policy; 2016 May; 31():168-71. PubMed ID: 27140430
[TBL] [Abstract][Full Text] [Related]
12. Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.
Mohamoud YA; Miller FD; Abu-Raddad LJ
World J Gastroenterol; 2014 Sep; 20(36):12734-52. PubMed ID: 25278675
[TBL] [Abstract][Full Text] [Related]
13. Scoping review of sexual and reproductive healthcare for men in the MENA (Middle East and North Africa) region: a handful of paradoxes?
El Ansari W; Arafa M; Elbardisi H; Majzoub A; Mahdi M; Albakr A; AlRumaihi K; Al Ansari A
BMC Public Health; 2023 Mar; 23(1):564. PubMed ID: 36973770
[TBL] [Abstract][Full Text] [Related]
14. Is UNAIDS 90-90-90 target a Dream or a Reality for Middle East and North Africa Region on Ending the AIDS Epidemic? A Review Study.
Joulaei H; Shooshtarian S; Dianatinasab M
AIDS Rev; 2018; 20(2):83-93. PubMed ID: 29938702
[TBL] [Abstract][Full Text] [Related]
15. HSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa.
Abu-Raddad LJ; Schiffer JT; Ashley R; Mumtaz G; Alsallaq RA; Akala FA; Semini I; Riedner G; Wilson D
Epidemics; 2010 Dec; 2(4):173-82. PubMed ID: 21352788
[TBL] [Abstract][Full Text] [Related]
16. Are HIV epidemics among men who have sex with men emerging in the Middle East and North Africa?: a systematic review and data synthesis.
Mumtaz G; Hilmi N; McFarland W; Kaplan RL; Akala FA; Semini I; Riedner G; Tawil O; Wilson D; Abu-Raddad LJ
PLoS Med; 2010 Aug; 8(8):e1000444. PubMed ID: 21829329
[TBL] [Abstract][Full Text] [Related]
17. Improving the Quality and Quantity of HIV Data in the Middle East and North Africa: Key Challenges and Ways Forward.
Karamouzian M; Madani N; Doroudi F; Haghdoost AA
Int J Health Policy Manag; 2017 Feb; 6(2):65-69. PubMed ID: 28812781
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus epidemiology in populations with normal or abnormal cervical cytology or cervical cancer in the Middle East and North Africa: A systematic review and meta-analysis.
Obeid DA; Almatrrouk SA; Alfageeh MB; Al-Ahdal MNA; Alhamlan FS
J Infect Public Health; 2020 Sep; 13(9):1304-1313. PubMed ID: 32564935
[TBL] [Abstract][Full Text] [Related]
19. HIV surveillance in MENA: recent developments and results.
Bozicevic I; Riedner G; Calleja JM
Sex Transm Infect; 2013 Nov; 89 Suppl 3(Suppl 3):iii11-16. PubMed ID: 23434789
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological features of HIV/AIDS in the Middle East and North Africa from 1990 to 2017.
Shakiba E; Ramazani U; Mardani E; Rahimi Z; Nazar ZM; Najafi F; Moradinazar M
Int J STD AIDS; 2021 Mar; 32(3):257-265. PubMed ID: 33525959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
